Clinical Trials Directory

Trials / Conditions / Cutaneous Neurofibroma

Cutaneous Neurofibroma

10 registered clinical trials studyying Cutaneous Neurofibroma — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingFeasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1
NCT07102394
Johns Hopkins UniversityPhase 1
RecruitingMirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).
NCT06159166
Johns Hopkins UniversityPhase 1 / Phase 2
CompletedDPCP to Treat Cutaneous Neurofibromas Associated With NF1
NCT05438290
Nicholas GulatiPhase 1
CompletedHIFU Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1: Safety and Efficacy
NCT05119582
Joergen SerupN/A
CompletedNFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)
NCT05005845
NFlection Therapeutics, Inc.Phase 2
Active Not RecruitingNatural History Study of Cutaneous Neurofibromas in People With NF1
NCT05581511
Johns Hopkins University—
CompletedTolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas
NCT04730583
Massachusetts General HospitalPhase 1
CompletedNFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)
NCT04435665
NFlection Therapeutics, Inc.Phase 2
CompletedSelumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma
NCT02839720
National Cancer Institute (NCI)Phase 2
CompletedUse of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1
NCT03090971
Fundação Educacional Serra dos ÓrgãosPhase 2